Insider holders · CIK 0000875320
VERTEX PHARMACEUTICALS INC / MA · VRTX
Every insider with a reported Table I holding at this company, ranked by their last-reported share count. A balance is only as fresh as its filing — the report date sits next to every row on purpose. ← Back to activity
| Insider | Direct shares | Indirect shares | Total reported | Last report (ET) | From |
|---|---|---|---|---|---|
| Joshua S BogerDirector | 284,088 | 64,525 | 348,613 | Jun 9, 2017 · 4:31 pm EDT | Form 4 |
| Jeffrey M LeidenCEO & President | 106,195 | 440 | 106,635 | Feb 21, 2019 · 4:24 pm EST | Form 4 |
| Amit SachdevEVP Chief Patient & Ext Af Off | 66,512 | 6,637 | 73,149 | Jul 23, 2026 · 4:13 pm EDT | Form 4 |
| Jeffrey ChodakewitzEVP GMDA, CMO | 69,663 | — | 69,663 | Feb 14, 2018 · 6:15 pm EST | Form 4 |
| Ourania TatsisEVP, Chief Reg. & Quality Off. | 53,572 | — | 53,572 | Jul 23, 2026 · 4:15 pm EDT | Form 4 |
| Ian F SmithEVP, COO | 46,699 | 5,306 | 52,005 | Jul 3, 2018 · 4:25 pm EDT | Form 4 |
| Stuart A ArbuckleEVP\Chief Commercial Officer | 38,864 | 140 | 39,004 | Feb 13, 2019 · 4:37 pm EST | Form 4 |
| Bruce I SachsDirector | 39,000 | — | 39,000 | Aug 31, 2026 · 4:20 pm EDT | Form 4 |
| Michael PariniEVP, CL&AO | 35,003 | — | 35,003 | Feb 21, 2019 · 4:26 pm EST | Form 4 |
| David AltshulerEVP, Global Research and CSO | 31,553 | — | 31,553 | Feb 21, 2019 · 4:21 pm EST | Form 4 |
| Joy LiuEVP and Chief Legal Officer | 19,131 | — | 19,131 | Jul 6, 2026 · 4:13 pm EDT | Form 4 |
| Paul M SilvaSVP & Interim CFO | 17,759 | 169 | 17,928 | Feb 21, 2019 · 4:27 pm EST | Form 4 |
| Carmen BozicEVP and CMO | 15,337 | — | 15,337 | Jun 30, 2026 · 4:09 pm EDT | Form 4 |
| Reshma KewalramaniEVP and CMO | 13,736 | — | 13,736 | Feb 21, 2019 · 4:22 pm EST | Form 4 |
| Thomas GraneyChief Financial Officer | 12,430 | — | 12,430 | Oct 2, 2018 · 4:24 pm EDT | Form 4 |
| Elaine UllianDirector | 12,195 | — | 12,195 | Jun 5, 2018 · 4:38 pm EDT | Form 4 |
| Kristen AmbroseSVP & Chief Accounting Officer | 11,624 | — | 11,624 | Sep 1, 2026 · 4:39 pm EDT | Form 4 |
| Duncan McKechnieEVP, Chief Commercial Officer | 11,001 | — | 11,001 | Jul 7, 2026 · 4:08 pm EDT | Form 4 |
| Jasper van GrunsvenEVP, CP and NPPO | 8,682 | — | 8,682 | Sep 10, 2026 · 4:31 pm EDT | Form 4 |
| Terrence C KearneyDirector | 8,430 | — | 8,430 | Jun 5, 2018 · 4:58 pm EDT | Form 4 |
| William D YoungDirector | 6,930 | — | 6,930 | Jun 5, 2018 · 4:30 pm EDT | Form 4 |
| Yuchun LeeDirector | 6,648 | — | 6,648 | Jun 5, 2018 · 4:48 pm EDT | Form 4 |
| Margaret G McGlynnDirector | 5,925 | — | 5,925 | Jun 5, 2018 · 5:45 pm EDT | Form 4 |
| Sangeeta N. BhatiaDirector | 4,879 | — | 4,879 | Oct 5, 2018 · 5:28 pm EDT | Form 4 |
| Alan M GarberDirector | 4,000 | — | 4,000 | Jun 5, 2018 · 5:13 pm EDT | Form 4 |
| Lloyd CarneyDirector | 2,161 | — | 2,161 | Feb 22, 2019 · 4:12 pm EST | Form 4 |
| Wayne Joseph RileyDirector | 400 | — | 400 | Mar 24, 2015 · 5:59 pm EDT | Form 4 |
Balances come from each insider’s most recent filing that reports a Table I holding; an insider who left the company years ago still appears with their last-known figure and its date. Indirect totals collapse multiple vehicles (trusts, LLCs) into one number — open the filing for the breakdown. Shares as filed, not split-adjusted.